BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8962342)

  • 1. Cyclosporine control of recipient lymphocyte traffic to the heart allograft.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1996 Dec; 28(6):3441-3. PubMed ID: 8962342
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptively transferred lymphocytes from donors treated with cyclosporine reveal less predilection to migrate to allografts.
    Maksymowicz M; Olszewski WL; Szczesny G
    Transplant Proc; 1994 Dec; 26(6):3519. PubMed ID: 7998257
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of cyclosporine A on lymphocyte traffic in heart graft recipients.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 1994 Oct; 26(5):2863-4. PubMed ID: 7940902
    [No Abstract]   [Full Text] [Related]  

  • 4. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
    Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.
    Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H
    Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporin A decreases lymphocyte migration to the heart allograft through suppression of their L-selectin expression.
    Maksymowicz M; Lukomska B; Ziółkowska A; Janczewska S; Cybulska E; Olszewski WL
    Ann Transplant; 1998; 3(1):34-6. PubMed ID: 9869896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of ultraviolet-B-irradiated donor-specific blood transfusion and cyclosporine on cardiac allograft survival and mixed lymphocyte reaction in rats.
    Koh YB; Park IY; Lee YK
    Transplant Proc; 1994 Aug; 26(4):1952-3. PubMed ID: 8066632
    [No Abstract]   [Full Text] [Related]  

  • 9. Alloantigen modifies lymphocyte migration in graft recipients.
    Maksymowicz M; Olszewski WL
    Transplant Proc; 2000 Sep; 32(6):1393-4. PubMed ID: 10995992
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of lymph node CTL generation by spleen cells from cyclosporine-treated cardiac-allografted rats.
    Uhteg LC; Kupiec-Weglinski JW; Tilney NL; Carpenter CB
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1189-90. PubMed ID: 3274304
    [No Abstract]   [Full Text] [Related]  

  • 11. Different mechanisms of rejection of organ and cell allografts.
    Olszewski WL; Jasklowska-Englisz M; Lukomska B
    Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel effect of cyclosporine A on lymphocyte migration to allograft and recipient lymphoid tissue.
    Maksymowicz M; Ziolkowska A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1998 Dec; 30(8):4054-6. PubMed ID: 9865292
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of sandimmun and neoral on migration of lymph cells to allograft and lymphoid tissue.
    Maksymowicz M; Olszewski WL; Zaleska M
    Transplant Proc; 2000 Sep; 32(6):1400-2. PubMed ID: 10995995
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic lymphocyte cytotoxicity. Evidence that target cells include most, if not all, donor lymphocytes.
    Ford WL; Heslop BF
    Transplantation; 1987 May; 43(5):753-7. PubMed ID: 3576680
    [No Abstract]   [Full Text] [Related]  

  • 15. Allogeneic and xenogeneic cross-reactions in hyperimmune recipients.
    Di Stefano R; Carobbi A; Frosini F; Scavuzzo M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):446. PubMed ID: 8438372
    [No Abstract]   [Full Text] [Related]  

  • 16. Early experience with cyclosporine: a historic perspective.
    Kostakis A
    Transplant Proc; 2004 Mar; 36(2 Suppl):22S-24S. PubMed ID: 15041302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic lymphocytes are rejected in hyperacute fashion by enhanced rats bearing a heart allograft from the same donor.
    Olszewski WL; Orlewska E; Ryffa T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):244-5. PubMed ID: 2650111
    [No Abstract]   [Full Text] [Related]  

  • 18. Gamma-interferon-like substance is expressed in myocytes of cardiac allografted rats treated with cyclosporine A.
    Wanders A; Wells AF; Tufveson G; Klareskog L
    Transplant Proc; 1992 Feb; 24(1):346. PubMed ID: 1539309
    [No Abstract]   [Full Text] [Related]  

  • 19. A single exposure to ultraviolet radiation in vivo suppresses allogeneic responses in rat mixed lymphocyte cultures.
    Graudenz MS; Thiru S; Brons G; Fulford A
    Transplant Proc; 1990 Oct; 22(5):2338-9. PubMed ID: 2219396
    [No Abstract]   [Full Text] [Related]  

  • 20. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.